Trexquant Investment’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-386,263
| Closed | -$4.75M | – | 1849 |
|
|
2025
Q1 | $4.75M | Sell |
386,263
-85,029
| -18% | -$1.04M | 0.06% | 527 |
|
|
2024
Q4 | $6.23M | Buy |
471,292
+437,859
| +1,310% | +$5.79M | 0.07% | 441 |
|
|
2024
Q3 | $644K | Sell |
33,433
-60,473
| -64% | -$1.16M | 0.01% | 1189 |
|
|
2024
Q2 | $1.93M | Buy |
93,906
+19,314
| +26% | +$397K | 0.03% | 767 |
|
|
2024
Q1 | $1.78M | Sell |
74,592
-68,922
| -48% | -$1.64M | 0.04% | 696 |
|
|
2023
Q4 | $3.1M | Buy |
+143,514
| New | +$3.1M | 0.07% | 406 |
|
|
2023
Q3 | – | Sell |
-65,657
| Closed | -$1.37M | – | 1798 |
|
|
2023
Q2 | $1.37M | Buy |
65,657
+21,678
| +49% | +$454K | 0.04% | 642 |
|
|
2023
Q1 | $929K | Buy |
43,979
+33,436
| +317% | +$706K | 0.03% | 763 |
|
|
2022
Q4 | $268K | Buy |
+10,543
| New | +$268K | 0.01% | 1139 |
|
|
2021
Q1 | – | Sell |
-14,997
| Closed | -$334K | – | 1437 |
|
|
2020
Q4 | $334K | Sell |
14,997
-13,312
| -47% | -$296K | 0.04% | 634 |
|
|
2020
Q3 | $418K | Buy |
28,309
+10,874
| +62% | +$161K | 0.03% | 777 |
|
|
2020
Q2 | $258K | Buy |
+17,435
| New | +$258K | 0.02% | 953 |
|
|
2018
Q1 | – | Sell |
-40,274
| Closed | -$353K | – | 1354 |
|
|
2017
Q4 | $353K | Buy |
40,274
+28,923
| +255% | +$254K | 0.04% | 668 |
|
|
2017
Q3 | $133K | Buy |
+11,351
| New | +$133K | 0.03% | 700 |
|
|
2017
Q2 | – | Sell |
-20,595
| Closed | -$283K | – | 1135 |
|
|
2017
Q1 | $283K | Buy |
+20,595
| New | +$283K | 0.04% | 784 |
|